IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q1 2021 Holdings

Filed 2021-05-14 | 15 holdings | $390.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$373.8M6,068,12595.9%
Aclaris Theraputics Inc. (Acrs)(ACRS)COM00461U105$16.0M634,4554.1%
Harmony Biosciences Holdings Inc. (Hrmy)(HRMY)COM413197104$27.8K842,8150.0%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$26.6K2,541,0090.0%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$22.9K1,025,0000.0%
Spruce Biosciences, Inc. (Sprb)COM85209E109$20.0K1,205,5110.0%
Aeglea Biotherapeutics Inc. (Agle)(AGLEUSD)COM00773J103$13.4K1,691,1510.0%
Avrobio, Inc. (Avro)COM05455M100$12.8K1,009,7790.0%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$11.1K1,332,4850.0%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$10.0K1,043,2670.0%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$7.0K3,142,8570.0%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$5.9K387,6530.0%
ObsEva SA (Obsv)COMH5861P103$4.5K1,386,3380.0%
Zosano Pharma Corporation (Zsan)COM NEW98979H202$3.4K2,718,2260.0%
Nabriva Therapeutics plc (Nbrv)SHSG63637113$317191,0280.0%